Renvela 800mg Sachet

Visão geral do produto

About Renvela

Renvela is a medication containing the active ingredient Sevelamer. Sevelamer (rINN) is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Sevelamer carbonate tablets are indicated for the control of serum phosphorus in adults and children 6 years of age and older.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Sevelamer, the active ingredient in Renvela, is the pharmacologically active substance of this product. 1 INDICATIONS AND USAGE Sevelamer carbonate tablets are indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Renvela. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Renvela for extended periods without medical advice.